Guideline for Analgesic Management When NSAIDs Are Contraindicated

First‑Line Therapy: Acetaminophen

Acetaminophen should be used as the initial analgesic for any adult with a contraindication to NSAIDs, targeting musculoskeletal and osteoarthritis pain, because it provides comparable pain relief without gastrointestinal, renal, or cardiovascular toxicity. 1
The recommended maximum dose is 4 g per day for acute pain and 3 g per day for chronic use to reduce the risk of hepatotoxicity; dosing should be further reduced in patients with known liver disease. 2, 3, 1
Scheduled dosing (e.g., 650–1000 mg every 4–6 hours) is preferred over as‑needed dosing for chronic pain control. 4, 3
When acetaminophen is combined with opioid‑acetaminophen products, the total daily acetaminophen amount must be calculated to avoid exceeding the maximum dose. 2

For moderate pain that remains uncontrolled after optimal acetaminophen therapy, tramadol is the preferred next step before escalating to stronger opioids. 1
In osteoarthritis, tramadol administered in divided doses ranging from 37.5 mg to 400 mg daily over a three‑month period reduces pain intensity and improves functional ability. 1

Opioids are reserved for patients with moderate‑to‑severe pain and functional impairment that persists despite acetaminophen and tramadol, after a comprehensive risk assessment for misuse, diversion, and addiction. 1, 5
Initiate opioid therapy with the smallest effective dose, using a combination of short‑acting and long‑acting formulations when appropriate. 1
For pain rated 5–7 on a numeric rating scale, low‑dose strong opioids (e.g., morphine, oxycodone) or fixed‑dose combinations with acetaminophen are recommended. 4
Prior to prescribing, establish a written opioid patient‑provider agreement and implement routine monitoring (urine drug testing, pill counts). 1

Serotonin‑norepinephrine reuptake inhibitors (e.g., duloxetine) provide small‑to‑moderate pain relief. 5
Anticonvulsants such as gabapentin or pregabalin are effective for diabetic neuropathy and post‑herpetic neuralgia. 5
Topical lidocaine patches or capsaicin are useful for localized neuropathic pain. 5
Combining low‑dose morphine with gabapentin may yield additive analgesic effects while allowing lower individual doses. 1

Duloxetine, milnacipran, and pregabalin are FDA‑approved pharmacologic options. 5
Tricyclic antidepressants (e.g., amitriptyline) are frequently used despite limited supporting evidence. 5

Scheduled acetaminophen dosing remains the first‑line pharmacologic option. 5, 3
Duloxetine offers small‑to‑moderate benefit, especially in patients > 65 years with knee osteoarthritis. 5
Topical diclofenac can provide localized joint relief with minimal systemic absorption when only superficial joints are involved. 5

After failure of non‑pharmacologic measures, tramadol or opioid therapy may be considered, rather than NSAIDs. 5

Baseline and periodic monitoring of liver function tests are required for all patients on chronic analgesics. 2
Analgesics should be discontinued promptly if any of the following occur:
- Liver enzymes rise to > 3 × the upper limit of normal,
- New or worsening hypertension develops,
- Any bleeding event occurs, or
- Serum creatinine doubles from baseline. 2

Do not deem acetaminophen ineffective without first employing scheduled dosing at adequate total daily amounts (3–4 g). 3
Avoid combining multiple acetaminophen‑containing products without calculating the cumulative daily dose. 2
Opioids should never be used as first‑line therapy for chronic neuropathic pain; they are reserved for second‑ or third‑line use only. 1

Patients over 60 years have a markedly increased risk of GI bleeding and renal complications 6
Hematologic toxicity, including platelet dysfunction and bleeding risk, is a significant concern 7

The American Geriatrics Society recommends using the lowest effective dose for the shortest duration possible to minimize cardiovascular and GI risks, and considering COX-2 inhibitors for patients with a history of gastroduodenal ulcers or GI bleeding 7
Monitoring of blood pressure, renal function, liver function tests, complete blood count, and stool occult blood is crucial when using NSAIDs chronically 6
Discontinuation of NSAIDs is recommended if creatinine doubles, bleeding occurs, new-onset hypertension develops, or liver enzymes elevate 6

The Journal of the American Geriatrics Society recommends acetaminophen as the preferred first-line pharmacologic treatment for mild to moderate pain, providing comparable pain relief without GI side effects (maximum 4 grams daily) 7
Opioid analgesics are recommended as safer alternatives than NSAIDs in high-risk patients with bleeding disorders, anemia, renal impairment, or age >60 years 8